1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Microbiome Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Upper GIT 1.2.3 Lower GIT 1.3 Market by Application 1.3.1 Global Microbiome Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Inflammatory Bowel Disease (IBD) 1.3.3 Orphan Drug 1.3.4 Immuno-Oncology 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Microbiome Therapeutics Market Perspective (2016-2027) 2.2 Microbiome Therapeutics Growth Trends by Regions 2.2.1 Microbiome Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Microbiome Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Microbiome Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Microbiome Therapeutics Industry Dynamic 2.3.1 Microbiome Therapeutics Market Trends 2.3.2 Microbiome Therapeutics Market Drivers 2.3.3 Microbiome Therapeutics Market Challenges 2.3.4 Microbiome Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Microbiome Therapeutics Players by Revenue 3.1.1 Global Top Microbiome Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Microbiome Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Microbiome Therapeutics Revenue 3.4 Global Microbiome Therapeutics Market Concentration Ratio 3.4.1 Global Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapeutics Revenue in 2020 3.5 Microbiome Therapeutics Key Players Head office and Area Served 3.6 Key Players Microbiome Therapeutics Product Solution and Service 3.7 Date of Enter into Microbiome Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Microbiome Therapeutics Breakdown Data by Type 4.1 Global Microbiome Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Microbiome Therapeutics Forecasted Market Size by Type (2022-2027) 5 Microbiome Therapeutics Breakdown Data by Application 5.1 Global Microbiome Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Microbiome Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Microbiome Therapeutics Market Size (2016-2027) 6.2 North America Microbiome Therapeutics Market Size by Type 6.2.1 North America Microbiome Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Microbiome Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Microbiome Therapeutics Market Size by Type (2016-2027) 6.3 North America Microbiome Therapeutics Market Size by Application 6.3.1 North America Microbiome Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Microbiome Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Microbiome Therapeutics Market Size by Application (2016-2027) 6.4 North America Microbiome Therapeutics Market Size by Country 6.4.1 North America Microbiome Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Microbiome Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Microbiome Therapeutics Market Size (2016-2027) 7.2 Europe Microbiome Therapeutics Market Size by Type 7.2.1 Europe Microbiome Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Microbiome Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Microbiome Therapeutics Market Size by Type (2016-2027) 7.3 Europe Microbiome Therapeutics Market Size by Application 7.3.1 Europe Microbiome Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Microbiome Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Microbiome Therapeutics Market Size by Application (2016-2027) 7.4 Europe Microbiome Therapeutics Market Size by Country 7.4.1 Europe Microbiome Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Microbiome Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Microbiome Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Microbiome Therapeutics Market Size by Type 8.2.1 Asia-Pacific Microbiome Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Microbiome Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Microbiome Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Microbiome Therapeutics Market Size by Application 8.3.1 Asia-Pacific Microbiome Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Microbiome Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Microbiome Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Microbiome Therapeutics Market Size by Region 8.4.1 Asia-Pacific Microbiome Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Microbiome Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Microbiome Therapeutics Market Size (2016-2027) 9.2 Latin America Microbiome Therapeutics Market Size by Type 9.2.1 Latin America Microbiome Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Microbiome Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Microbiome Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Microbiome Therapeutics Market Size by Application 9.3.1 Latin America Microbiome Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Microbiome Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Microbiome Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Microbiome Therapeutics Market Size by Country 9.4.1 Latin America Microbiome Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Microbiome Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Microbiome Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Microbiome Therapeutics Market Size by Type 10.2.1 Middle East & Africa Microbiome Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Microbiome Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Microbiome Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Microbiome Therapeutics Market Size by Application 10.3.1 Middle East & Africa Microbiome Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Microbiome Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Microbiome Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Microbiome Therapeutics Market Size by Country 10.4.1 Middle East & Africa Microbiome Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Microbiome Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Seres Therapeutics 11.1.1 Seres Therapeutics Company Details 11.1.2 Seres Therapeutics Business Overview 11.1.3 Seres Therapeutics Microbiome Therapeutics Introduction 11.1.4 Seres Therapeutics Revenue in Microbiome Therapeutics Business (2016-2021) 11.1.5 Seres Therapeutics Recent Development 11.2 Assembly Biosciences 11.2.1 Assembly Biosciences Company Details 11.2.2 Assembly Biosciences Business Overview 11.2.3 Assembly Biosciences Microbiome Therapeutics Introduction 11.2.4 Assembly Biosciences Revenue in Microbiome Therapeutics Business (2016-2021) 11.2.5 Assembly Biosciences Recent Development 11.3 Synthetic Biologics 11.3.1 Synthetic Biologics Company Details 11.3.2 Synthetic Biologics Business Overview 11.3.3 Synthetic Biologics Microbiome Therapeutics Introduction 11.3.4 Synthetic Biologics Revenue in Microbiome Therapeutics Business (2016-2021) 11.3.5 Synthetic Biologics Recent Development 11.4 Interxon 11.4.1 Interxon Company Details 11.4.2 Interxon Business Overview 11.4.3 Interxon Microbiome Therapeutics Introduction 11.4.4 Interxon Revenue in Microbiome Therapeutics Business (2016-2021) 11.4.5 Interxon Recent Development 11.5 PureTech 11.5.1 PureTech Company Details 11.5.2 PureTech Business Overview 11.5.3 PureTech Microbiome Therapeutics Introduction 11.5.4 PureTech Revenue in Microbiome Therapeutics Business (2016-2021) 11.5.5 PureTech Recent Development 11.6 Synlogic 11.6.1 Synlogic Company Details 11.6.2 Synlogic Business Overview 11.6.3 Synlogic Microbiome Therapeutics Introduction 11.6.4 Synlogic Revenue in Microbiome Therapeutics Business (2016-2021) 11.6.5 Synlogic Recent Development 11.7 Enterome BioScience 11.7.1 Enterome BioScience Company Details 11.7.2 Enterome BioScience Business Overview 11.7.3 Enterome BioScience Microbiome Therapeutics Introduction 11.7.4 Enterome BioScience Revenue in Microbiome Therapeutics Business (2016-2021) 11.7.5 Enterome BioScience Recent Development 11.8 4D Pharma 11.8.1 4D Pharma Company Details 11.8.2 4D Pharma Business Overview 11.8.3 4D Pharma Microbiome Therapeutics Introduction 11.8.4 4D Pharma Revenue in Microbiome Therapeutics Business (2016-2021) 11.8.5 4D Pharma Recent Development 11.9 Second Genome 11.9.1 Second Genome Company Details 11.9.2 Second Genome Business Overview 11.9.3 Second Genome Microbiome Therapeutics Introduction 11.9.4 Second Genome Revenue in Microbiome Therapeutics Business (2016-2021) 11.9.5 Second Genome Recent Development 11.10 AOBiome 11.10.1 AOBiome Company Details 11.10.2 AOBiome Business Overview 11.10.3 AOBiome Microbiome Therapeutics Introduction 11.10.4 AOBiome Revenue in Microbiome Therapeutics Business (2016-2021) 11.10.5 AOBiome Recent Development 11.11 C3 Jian 11.11.1 C3 Jian Company Details 11.11.2 C3 Jian Business Overview 11.11.3 C3 Jian Microbiome Therapeutics Introduction 11.11.4 C3 Jian Revenue in Microbiome Therapeutics Business (2016-2021) 11.11.5 C3 Jian Recent Development 11.12 Rebiotix 11.12.1 Rebiotix Company Details 11.12.2 Rebiotix Business Overview 11.12.3 Rebiotix Microbiome Therapeutics Introduction 11.12.4 Rebiotix Revenue in Microbiome Therapeutics Business (2016-2021) 11.12.5 Rebiotix Recent Development 11.13 MicroBiome Therapeutics LLC 11.13.1 MicroBiome Therapeutics LLC Company Details 11.13.2 MicroBiome Therapeutics LLC Business Overview 11.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Introduction 11.13.4 MicroBiome Therapeutics LLC Revenue in Microbiome Therapeutics Business (2016-2021) 11.13.5 MicroBiome Therapeutics LLC Recent Development 11.14 Metabiomics 11.14.1 Metabiomics Company Details 11.14.2 Metabiomics Business Overview 11.14.3 Metabiomics Microbiome Therapeutics Introduction 11.14.4 Metabiomics Revenue in Microbiome Therapeutics Business (2016-2021) 11.14.5 Metabiomics Recent Development 11.15 Ritter Pharmaceuticals 11.15.1 Ritter Pharmaceuticals Company Details 11.15.2 Ritter Pharmaceuticals Business Overview 11.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Introduction 11.15.4 Ritter Pharmaceuticals Revenue in Microbiome Therapeutics Business (2016-2021) 11.15.5 Ritter Pharmaceuticals Recent Development 11.16 Symberix 11.16.1 Symberix Company Details 11.16.2 Symberix Business Overview 11.16.3 Symberix Microbiome Therapeutics Introduction 11.16.4 Symberix Revenue in Microbiome Therapeutics Business (2016-2021) 11.16.5 Symberix Recent Development 11.17 OpenBiome 11.17.1 OpenBiome Company Details 11.17.2 OpenBiome Business Overview 11.17.3 OpenBiome Microbiome Therapeutics Introduction 11.17.4 OpenBiome Revenue in Microbiome Therapeutics Business (2016-2021) 11.17.5 OpenBiome Recent Development 11.18 Azitra 11.18.1 Azitra Company Details 11.18.2 Azitra Business Overview 11.18.3 Azitra Microbiome Therapeutics Introduction 11.18.4 Azitra Revenue in Microbiome Therapeutics Business (2016-2021) 11.18.5 Azitra Recent Development 11.18 Symbiotix Biotherapies .1 Symbiotix Biotherapies Company Details .2 Symbiotix Biotherapies Business Overview .3 Symbiotix Biotherapies Microbiome Therapeutics Introduction .4 Symbiotix Biotherapies Revenue in Microbiome Therapeutics Business (2016-2021) .5 Symbiotix Biotherapies Recent Development 11.20 Osel 11.20.1 Osel Company Details 11.20.2 Osel Business Overview 11.20.3 Osel Microbiome Therapeutics Introduction 11.20.4 Osel Revenue in Microbiome Therapeutics Business (2016-2021) 11.20.5 Osel Recent Development 11.21 Metabogen 11.21.1 Metabogen Company Details 11.21.2 Metabogen Business Overview 11.21.3 Metabogen Microbiome Therapeutics Introduction 11.21.4 Metabogen Revenue in Microbiome Therapeutics Business (2016-2021) 11.21.5 Metabogen Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Upper GIT Table 3. Key Players of Lower GIT Table 4. Global Microbiome Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Microbiome Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Microbiome Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Microbiome Therapeutics Market Share by Regions (2016-2021) Table 8. Global Microbiome Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Microbiome Therapeutics Market Share by Regions (2022-2027) Table 10. Microbiome Therapeutics Market Trends Table 11. Microbiome Therapeutics Market Drivers Table 12. Microbiome Therapeutics Market Challenges Table 13. Microbiome Therapeutics Market Restraints Table 14. Global Microbiome Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Microbiome Therapeutics Market Share by Players (2016-2021) Table 16. Global Top Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Therapeutics as of 2020) Table 17. Ranking of Global Top Microbiome Therapeutics Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Microbiome Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Microbiome Therapeutics Product Solution and Service Table 21. Date of Enter into Microbiome Therapeutics Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 24. Global Microbiome Therapeutics Revenue Market Share by Type (2016-2021) Table 25. Global Microbiome Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Microbiome Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Microbiome Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Microbiome Therapeutics Revenue Market Share by Application (2016-2021) Table 29. Global Microbiome Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Microbiome Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 32. North America Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 34. North America Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Microbiome Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Microbiome Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 61. Seres Therapeutics Company Details Table 62. Seres Therapeutics Business Overview Table 63. Seres Therapeutics Microbiome Therapeutics Product Table 64. Seres Therapeutics Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 65. Seres Therapeutics Recent Development Table 66. Assembly Biosciences Company Details Table 67. Assembly Biosciences Business Overview Table 68. Assembly Biosciences Microbiome Therapeutics Product Table 69. Assembly Biosciences Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 70. Assembly Biosciences Recent Development Table 71. Synthetic Biologics Company Details Table 72. Synthetic Biologics Business Overview Table 73. Synthetic Biologics Microbiome Therapeutics Product Table 74. Synthetic Biologics Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 75. Synthetic Biologics Recent Development Table 76. Interxon Company Details Table 77. Interxon Business Overview Table 78. Interxon Microbiome Therapeutics Product Table 79. Interxon Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 80. Interxon Recent Development Table 81. PureTech Company Details Table 82. PureTech Business Overview Table 83. PureTech Microbiome Therapeutics Product Table 84. PureTech Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 85. PureTech Recent Development Table 86. Synlogic Company Details Table 87. Synlogic Business Overview Table 88. Synlogic Microbiome Therapeutics Product Table 89. Synlogic Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 90. Synlogic Recent Development Table 91. Enterome BioScience Company Details Table 92. Enterome BioScience Business Overview Table 93. Enterome BioScience Microbiome Therapeutics Product Table 94. Enterome BioScience Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 95. Enterome BioScience Recent Development Table 96. 4D Pharma Company Details Table 97. 4D Pharma Business Overview Table 98. 4D Pharma Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 99. 4D Pharma Recent Development Table 100. Second Genome Company Details Table 101. Second Genome Business Overview Table 102. Second Genome Microbiome Therapeutics Product Table 103. Second Genome Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 104. Second Genome Recent Development Table 105. AOBiome Company Details Table 106. AOBiome Business Overview Table 107. AOBiome Microbiome Therapeutics Product Table 108. AOBiome Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 109. AOBiome Recent Development Table 110. C3 Jian Company Details Table 111. C3 Jian Business Overview Table 112. C3 Jian Microbiome Therapeutics Product Table 113. C3 Jian Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 114. C3 Jian Recent Development Table 115. Rebiotix Company Details Table 116. Rebiotix Business Overview Table 117. Rebiotix Microbiome Therapeutics Product Table 118. Rebiotix Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 119. Rebiotix Recent Development Table 120. MicroBiome Therapeutics LLC Company Details Table 121. MicroBiome Therapeutics LLC Business Overview Table 122. MicroBiome Therapeutics LLC Microbiome Therapeutics Product Table 123. MicroBiome Therapeutics LLC Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 124. MicroBiome Therapeutics LLC Recent Development Table 125. Metabiomics Company Details Table 126. Metabiomics Business Overview Table 127. Metabiomics Microbiome Therapeutics Product Table 128. Metabiomics Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 129. Metabiomics Recent Development Table 130. Ritter Pharmaceuticals Company Details Table 131. Ritter Pharmaceuticals Business Overview Table 132. Ritter Pharmaceuticals Microbiome Therapeutics Product Table 133. Ritter Pharmaceuticals Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 134. Ritter Pharmaceuticals Recent Development Table 135. Symberix Company Details Table 136. Symberix Business Overview Table 137. Symberix Microbiome Therapeutics Product Table 138. Symberix Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 139. Symberix Recent Development Table 140. OpenBiome Company Details Table 141. OpenBiome Business Overview Table 142. OpenBiome Microbiome Therapeutics Product Table 143. OpenBiome Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 144. OpenBiome Recent Development Table 145. Azitra Company Details Table 146. Azitra Business Overview Table 147. Azitra Microbiome Therapeutics Product Table 148. Azitra Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 149. Azitra Recent Development Table 150. Symbiotix Biotherapies Company Details Table 151. Symbiotix Biotherapies Business Overview Table 152. Symbiotix Biotherapies Microbiome Therapeutics Product Table 153. Symbiotix Biotherapies Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 154. Symbiotix Biotherapies Recent Development Table 155. Osel Company Details Table 156. Osel Business Overview Table 157. Osel Microbiome Therapeutics Product Table 158. Osel Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 159. Osel Recent Development Table 160. Metabogen Company Details Table 161. Metabogen Business Overview Table 162. Metabogen Microbiome Therapeutics Product Table 163. Metabogen Revenue in Microbiome Therapeutics Business (2016-2021) & (US$ Million) Table 164. Metabogen Recent Development Table 165. Research Programs/Design for This Report Table 166. Key Data Information from Secondary Sources Table 167. Key Data Information from Primary Sources List of Figures Figure 1. Global Microbiome Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Upper GIT Features Figure 3. Lower GIT Features Figure 4. Global Microbiome Therapeutics Market Share by Application: 2020 VS 2027 Figure 5. Inflammatory Bowel Disease (IBD) Case Studies Figure 6. Orphan Drug Case Studies Figure 7. Immuno-Oncology Case Studies Figure 8. Others Case Studies Figure 9. Microbiome Therapeutics Report Years Considered Figure 10. Global Microbiome Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Microbiome Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Microbiome Therapeutics Market Share by Regions: 2020 VS 2027 Figure 13. Global Microbiome Therapeutics Market Share by Regions (2022-2027) Figure 14. Global Microbiome Therapeutics Market Share by Players in 2020 Figure 15. Global Top Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Therapeutics as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Microbiome Therapeutics Revenue in 2020 Figure 17. Global Microbiome Therapeutics Revenue Market Share by Type (2016-2021) Figure 18. Global Microbiome Therapeutics Revenue Market Share by Type (2022-2027) Figure 19. North America Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Microbiome Therapeutics Market Share by Type (2016-2027) Figure 21. North America Microbiome Therapeutics Market Share by Application (2016-2027) Figure 22. North America Microbiome Therapeutics Market Share by Country (2016-2027) Figure 23. United States Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Microbiome Therapeutics Market Share by Type (2016-2027) Figure 27. Europe Microbiome Therapeutics Market Share by Application (2016-2027) Figure 28. Europe Microbiome Therapeutics Market Share by Country (2016-2027) Figure 29. Germany Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Microbiome Therapeutics Market Share by Type (2016-2027) Figure 37. Asia-Pacific Microbiome Therapeutics Market Share by Application (2016-2027) Figure 38. Asia-Pacific Microbiome Therapeutics Market Share by Region (2016-2027) Figure 39. China Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Microbiome Therapeutics Market Share by Type (2016-2027) Figure 47. Latin America Microbiome Therapeutics Market Share by Application (2016-2027) Figure 48. Latin America Microbiome Therapeutics Market Share by Country (2016-2027) Figure 49. Mexico Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Microbiome Therapeutics Market Share by Type (2016-2027) Figure 53. Middle East & Africa Microbiome Therapeutics Market Share by Application (2016-2027) Figure 54. Middle East & Africa Microbiome Therapeutics Market Share by Country (2016-2027) Figure 55. Turkey Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Seres Therapeutics Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 59. Assembly Biosciences Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 60. Synthetic Biologics Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 61. Interxon Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 62. PureTech Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 63. Synlogic Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 64. Enterome BioScience Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 65. 4D Pharma Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 66. Second Genome Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 67. AOBiome Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 68. C3 Jian Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 69. Rebiotix Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 70. MicroBiome Therapeutics LLC Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 71. Metabiomics Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 72. Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 73. Symberix Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 74. OpenBiome Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 75. Azitra Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 76. Symbiotix Biotherapies Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 77. Osel Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 78. Metabogen Revenue Growth Rate in Microbiome Therapeutics Business (2016-2021) Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed